๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

4 recruiting trials

for Oligometastatic Prostate Cancer (OMPC)

JUR-003 in Adult Patients With Metastatic Prostate Cancer NCT07824349Phase 14 sites๐Ÿ“ Grand Rapids๐Ÿ“ Lake Success๐Ÿ“ Nashville Juri Biosciences, Inc. ยท Tests: JUR-003 Trial of pTVG-HP+Nivo+Targeted Ablation of Resistant Lesions in Non-Castrate RecurrentOMPC NCT07090148Phase 11 site๐Ÿ“ Madison University of Wisconsin, Madison ยท Tests: pTVG-HP DNA vaccine, Anti-PD-1 monoclonal antibody An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC. NCT05939414Phase 3144 sites๐Ÿ“ Fayetteville๐Ÿ“ Los Angeles๐Ÿ“ Palo Alto Novartis Pharmaceuticals ยท Tests: AAA617, piflufolastat (18F), gallium (68Ga) gozetotide (25ฮผg) HIghly MetAstatic Life Prolonging Therapy-Resistant Prostate Cancer: Role of Stereotactic Radiotherapy for Bone and Lymph Node Metastases (HIMARS) NCT06978296NA1 site๐Ÿ“ Saint-Herblain Institut Cancerologie de l'Ouest ยท Tests: Stereotactic body radiotherapy (SBRT)
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy